FDA approves generic abacavir sulfate tablets.
D002648:Child; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D000099227:Abacavir
D015224:Dideoxynucleosides; D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir